脱腫瘍性小円形細胞腫治療の世界市場レポート 2025年

脱腫瘍性小円形細胞腫治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で55億3,000万米ドルに成長します。予測期間の成長は、専門治療センターの増加、個別化医療の拡大、併用療法の増加、新薬承認の増加、がん治療に対するヘルスケア支出の増加に起因しています。予測期間における主な動向には、標的療法の採用、高度診断の統合、個別化医療の導入、遺伝子編集技術の進歩、強化型ドラッグデリバリーシステムの開発などがあります。

個別化医療が重視されるようになったことで、今後、脱腫瘍性小円形細胞腫（DSRCT）治療市場の成長が促進されると予測されます。個別化医療には、個人固有の遺伝子プロファイル、ライフスタイル、環境に合わせたヘルスケアが含まれます。これは、より正確で効果的な治療を提供するために、薬理ゲノミクス、標的治療、遺伝子編集などの戦略を包含しています。個別化医療への注目の高まりは、ゲノミクスの進歩、患者の転帰の向上、より的を絞った治療法の可能性などに後押しされています。DSRCTの場合、個別化医療は腫瘍の特定の遺伝的・分子的特徴に基づいた治療戦略を可能にし、有効性を高め副作用を最小限に抑える標的治療を促進します。例えば、米国の専門家会員組織である個別化医療連合（Personalized Medicine Coalition）は、2022年に承認された新治療法のうち、12の個別化新薬が占める割合は約34％であり、以前に比べて大幅に増加していると報告しています。このように、個別化医療への注目の高まりは、DSRCT治療市場の重要な促進要因となっています。

腫瘍学調査への投資の増加も、今後の同市場の成長を支えるものと期待されます。腫瘍学研究への資金提供の増加は、世界のがん罹患率の増加、精密医療の進歩、患者の予後を改善する革新的治療の必要性などが背景にあります。腫瘍学の研究は、腫瘍の生物学の理解を深めることでDSRCTの治療に貢献し、患者の転帰を改善する標的治療やより優れた治療プロトコルの開発につながります。例えば、米国を拠点とする国立がん研究所は2024年6月、2022会計年度の予算が前年度比5.7％増の約68億米ドルに達したと報告しました。そのため、腫瘍学研究への投資が増加しており、DSRCT治療市場を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界脱腫瘍性小円形細胞腫治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の脱腫瘍性小円形細胞腫治療市場：成長率分析
• 世界の脱腫瘍性小円形細胞腫治療市場の実績：規模と成長, 2019-2024
• 世界の脱腫瘍性小円形細胞腫治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界脱腫瘍性小円形細胞腫治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脱腫瘍性小円形細胞腫治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫療法
• 手術
• 化学療法
• 放射線療法
• 世界の脱腫瘍性小円形細胞腫治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞傷害性薬剤
• 標的療法
• 免疫調節薬
• 世界の脱腫瘍性小円形細胞腫治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 腫瘍学クリニック
• 外来手術センター
• 世界の脱腫瘍性小円形細胞腫治療市場免疫療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• チェックポイント阻害剤
• CAR T細胞療法
• モノクローナル抗体
• 免疫調節薬
• 世界の脱腫瘍性小円形細胞腫治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍切除
• 減量手術
• 腹腔鏡手術
• 世界の脱腫瘍性小円形細胞腫治療市場化学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 術前化学療法
• 補助化学療法
• 標的治療薬
• 世界の脱腫瘍性小円形細胞腫治療市場放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外部放射線治療（EBRT）
• 近接放射線療法
• 定位放射線手術（SRS）

第7章 地域別・国別分析

• 世界の脱腫瘍性小円形細胞腫治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の脱腫瘍性小円形細胞腫治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脱腫瘍性小円形細胞腫治療市場：競合情勢
• 脱腫瘍性小円形細胞腫治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis AG
• Fresenius Kabi AG
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Gilead Sciences Inc.
• Amgen Inc.
• GlaxoSmithKline plc（GSK）
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Aurobindo Pharma Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 脱腫瘍性小円形細胞腫治療市場2029：新たな機会を提供する国
• 脱腫瘍性小円形細胞腫治療市場2029：新たな機会を提供するセグメント
• 脱腫瘍性小円形細胞腫治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The treatment for desmoplastic small round cell tumor (DSRCT) involves various medical approaches, including surgery, chemotherapy, and radiation therapy, aimed at managing and controlling the progression of this rare and aggressive cancer. These treatments are designed to target and limit the spread of cancerous cells, particularly in the abdominal region. A significant benefit of DSRCT treatment is its potential to reduce tumor size, enhance survival rates, and improve the overall quality of life for patients.

The primary types of treatments in the desmoplastic small round cell tumor market include immunotherapy, surgical operations, chemotherapy, and radiotherapy. Immunotherapy is a treatment method that utilizes the body's immune system to combat diseases, especially cancer. The various drug classes involved comprise cytotoxic agents, targeted therapies, and immunomodulators, with multiple end users including hospitals, oncology clinics, and ambulatory surgical centers.

The desmoplastic small round cell tumor treatment market research report is one of a series of new reports from The Business Research Company that provides desmoplastic small round cell tumor treatment market statistics, including desmoplastic small round cell tumor treatment industry global market size, regional shares, competitors with a desmoplastic small round cell tumor treatment market share, detailed desmoplastic small round cell tumor treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the desmoplastic small round cell tumor treatment industry. This desmoplastic small round cell tumor treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The desmoplastic small round cell tumor treatment market size has grown strongly in recent years. It will grow from $3.7 billion in 2024 to $4.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rise in awareness of rare cancers, rise in number of clinical trials, growth in funding for rare cancer research, increase in availability of advanced diagnostics, and growth in immunotherapies and gene therapies.

The desmoplastic small round cell tumor treatment market size is expected to see strong growth in the next few years. It will grow to $5.53 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to growing specialized treatment centers, growing personalized medicine, rising use of combination therapies, growing new drug approvals, and rising healthcare expenditure on cancer treatment. Major trends in the forecast period include adoption of targeted therapies, integration of advanced diagnostics, implementation of personalized medicine, advancements in gene editing technologies, and development of enhanced drug delivery systems.

The growing emphasis on personalized medicine is projected to drive the growth of the desmoplastic small round cell tumor (DSRCT) treatment market in the future. Personalized medicine involves tailoring healthcare to an individual's unique genetic profile, lifestyle, and environment. It encompasses strategies such as pharmacogenomics, targeted therapies, and gene editing to deliver more precise and effective treatments. The increasing focus on personalized medicine is fueled by advancements in genomics, enhanced patient outcomes, and the potential for more targeted therapies. In the case of DSRCT, personalized medicine enables treatment strategies that are based on the specific genetic and molecular characteristics of the tumor, facilitating targeted therapies that enhance efficacy and minimize side effects. For example, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all new therapies approved, indicating a significant increase compared to previous years. Thus, the heightened focus on personalized medicine is a key driver of the DSRCT treatment market.

Increased investment in oncology research is also expected to support the growth of the desmoplastic small round cell tumor treatment market in the future. The rise in funding for oncology research is driven by the increasing incidence of cancer worldwide, advancements in precision medicine, and the need for innovative treatments to enhance patient outcomes. Research in oncology contributes to the treatment of DSRCT by improving the understanding of the tumor's biology, leading to the development of targeted therapies and better treatment protocols that improve patient outcomes. For instance, the National Cancer Institute, a US-based organization, reported in June 2024 that its budget for fiscal year 2022 was approximately $6.8 billion, reflecting a 5.7% increase from the previous year. Therefore, the growing investment in oncology research is propelling the DSRCT treatment market.

The increasing number of clinical trials is anticipated to drive the growth of the desmoplastic small round cell tumor treatment market moving forward. Clinical trials involve human volunteers and assess the safety and efficacy of new medical treatments or procedures, aiming to collect scientific data on their appropriateness for human use. The rise in clinical trials is largely attributed to advancements in medical research, the growing burden of diseases, regulatory changes, the globalization of clinical research, increased patient advocacy and awareness, competition within the industry, technological advancements, and new funding opportunities. Clinical trials provide access to innovative therapies and evaluate the effectiveness of new treatments, thereby improving patient outcomes and promoting the development of targeted and more effective treatment options. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,225 clinical trials registered globally by the end of 2023, up from 437,506 trials registered in 2022. Thus, the rising number of clinical trials is contributing to the growth of the desmoplastic small round cell tumor treatment market.

Major companies operating in the desmoplastic small round cell tumor treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Fresenius Kabi AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., GlaxoSmithKline plc (GSK), Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zymeworks Inc., Blueprint Medicines Corporation, MacroGenics Inc., Exelixis Inc

North America was the largest region in the desmoplastic small round cell tumor treatment market in 2023. The regions covered in the desmoplastic small round cell tumor treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the desmoplastic small round cell tumor treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The desmoplastic small round cell tumor treatment market includes revenues earned by entities by providing services such as immunotherapy, diagnostic imaging, and post treatment care, including rehabilitation and follow up monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Desmoplastic Small Round Cell Tumor Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on desmoplastic small round cell tumor treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for desmoplastic small round cell tumor treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The desmoplastic small round cell tumor treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Immunotherapy; Surgical Operation; Chemotherapy; Radiotherapy
• 2) By Drug Class: Cytotoxic Agents; Targeted Therapies; Immunomodulators
• 3) By End User: Hospitals; Oncology Clinics; Ambulatory Surgical Centers
• Subsegments:
• 1) By Immunotherapy: Checkpoint Inhibitors; CAR T-Cell Therapy; Monoclonal Antibodies; Immune Modulators
• 2) By Surgical Operation: Tumor Resection; Debulking Surgery; Laparoscopic Surgery
• 3) By Chemotherapy: Neoadjuvant Chemotherapy; Adjuvant Chemotherapy; Targeted Therapy Agents
• 4) By Radiotherapy: External Beam Radiation Therapy (EBRT); Brachytherapy; Stereotactic Radiosurgery (SRS)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Desmoplastic Small Round Cell Tumor Treatment Market Characteristics

3. Desmoplastic Small Round Cell Tumor Treatment Market Trends And Strategies

4. Desmoplastic Small Round Cell Tumor Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Desmoplastic Small Round Cell Tumor Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Desmoplastic Small Round Cell Tumor Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Desmoplastic Small Round Cell Tumor Treatment Market Growth Rate Analysis
• 5.4. Global Desmoplastic Small Round Cell Tumor Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Desmoplastic Small Round Cell Tumor Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Desmoplastic Small Round Cell Tumor Treatment Total Addressable Market (TAM)

6. Desmoplastic Small Round Cell Tumor Treatment Market Segmentation

• 6.1. Global Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunotherapy
• Surgical Operation
• Chemotherapy
• Radiotherapy
• 6.2. Global Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytotoxic Agents
• Targeted Therapies
• Immunomodulators
• 6.3. Global Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Oncology Clinics
• Ambulatory Surgical Centers
• 6.4. Global Desmoplastic Small Round Cell Tumor Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Checkpoint Inhibitors
• CAR T-Cell Therapy
• Monoclonal Antibodies
• Immune Modulators
• 6.5. Global Desmoplastic Small Round Cell Tumor Treatment Market, Sub-Segmentation Of Surgical Operation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Resection
• Debulking Surgery
• Laparoscopic Surgery
• 6.6. Global Desmoplastic Small Round Cell Tumor Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neoadjuvant Chemotherapy
• Adjuvant Chemotherapy
• Targeted Therapy Agents
• 6.7. Global Desmoplastic Small Round Cell Tumor Treatment Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy (EBRT)
• Brachytherapy
• Stereotactic Radiosurgery (SRS)

7. Desmoplastic Small Round Cell Tumor Treatment Market Regional And Country Analysis

• 7.1. Global Desmoplastic Small Round Cell Tumor Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Desmoplastic Small Round Cell Tumor Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Desmoplastic Small Round Cell Tumor Treatment Market

• 8.1. Asia-Pacific Desmoplastic Small Round Cell Tumor Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Desmoplastic Small Round Cell Tumor Treatment Market

• 9.1. China Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 9.2. China Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Desmoplastic Small Round Cell Tumor Treatment Market

• 10.1. India Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Desmoplastic Small Round Cell Tumor Treatment Market

• 11.1. Japan Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 11.2. Japan Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Desmoplastic Small Round Cell Tumor Treatment Market

• 12.1. Australia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Desmoplastic Small Round Cell Tumor Treatment Market

• 13.1. Indonesia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Desmoplastic Small Round Cell Tumor Treatment Market

• 14.1. South Korea Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 14.2. South Korea Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Desmoplastic Small Round Cell Tumor Treatment Market

• 15.1. Western Europe Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 15.2. Western Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Desmoplastic Small Round Cell Tumor Treatment Market

• 16.1. UK Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Desmoplastic Small Round Cell Tumor Treatment Market

• 17.1. Germany Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Desmoplastic Small Round Cell Tumor Treatment Market

• 18.1. France Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Desmoplastic Small Round Cell Tumor Treatment Market

• 19.1. Italy Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Desmoplastic Small Round Cell Tumor Treatment Market

• 20.1. Spain Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Desmoplastic Small Round Cell Tumor Treatment Market

• 21.1. Eastern Europe Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 21.2. Eastern Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Desmoplastic Small Round Cell Tumor Treatment Market

• 22.1. Russia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Desmoplastic Small Round Cell Tumor Treatment Market

• 23.1. North America Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 23.2. North America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Desmoplastic Small Round Cell Tumor Treatment Market

• 24.1. USA Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 24.2. USA Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Desmoplastic Small Round Cell Tumor Treatment Market

• 25.1. Canada Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 25.2. Canada Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Desmoplastic Small Round Cell Tumor Treatment Market

• 26.1. South America Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 26.2. South America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Desmoplastic Small Round Cell Tumor Treatment Market

• 27.1. Brazil Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Desmoplastic Small Round Cell Tumor Treatment Market

• 28.1. Middle East Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 28.2. Middle East Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Desmoplastic Small Round Cell Tumor Treatment Market

• 29.1. Africa Desmoplastic Small Round Cell Tumor Treatment Market Overview
• 29.2. Africa Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Desmoplastic Small Round Cell Tumor Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Desmoplastic Small Round Cell Tumor Treatment Market Competitive Landscape And Company Profiles

• 30.1. Desmoplastic Small Round Cell Tumor Treatment Market Competitive Landscape
• 30.2. Desmoplastic Small Round Cell Tumor Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Desmoplastic Small Round Cell Tumor Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis AG
• 31.6. Fresenius Kabi AG
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. Boehringer Ingelheim International GmbH
• 31.10. Gilead Sciences Inc.
• 31.11. Amgen Inc.
• 31.12. GlaxoSmithKline plc (GSK)
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Regeneron Pharmaceuticals Inc.
• 31.15. Aurobindo Pharma Limited

32. Global Desmoplastic Small Round Cell Tumor Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Desmoplastic Small Round Cell Tumor Treatment Market

34. Recent Developments In The Desmoplastic Small Round Cell Tumor Treatment Market

35. Desmoplastic Small Round Cell Tumor Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Desmoplastic Small Round Cell Tumor Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Desmoplastic Small Round Cell Tumor Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Desmoplastic Small Round Cell Tumor Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer